Form 4: InMed Pharmaceuticals Consultant Alexandra Mancini Reports Sale of Common Stock
SEC Form 4 Filing
Alexandra Diane Janet Mancini, a consultant for InMed Pharmaceuticals, reported selling 240 shares of common stock on July 31, 2024.
Summary
- On August 2, 2024, Alexandra Diane Janet Mancini, a consultant for InMed Pharmaceuticals Inc., filed a Form 4 with the SEC.
- The report details a transaction on July 31, 2024, where Mancini disposed of 240 shares of common stock.
- The sale price was $0.1763 per share.
- Following the transaction, Mancini's direct ownership of common stock is reported as zero.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing detailing a stock sale. It doesn't inherently convey positive or negative sentiment about the company's prospects.
Industry Context
This filing is a routine disclosure of stock transactions by an insider, providing transparency to the market regarding the consultant's trading activities in the company's stock.
Stakeholder Impact
- The stock sale by a consultant could have a minor impact on shareholder sentiment, but is unlikely to be significant given the small number of shares involved.
Key Dates
| Date | Description |
|---|---|
| 07/31/2024 | Date of stock sale transaction. |
| 08/02/2024 | Date of Form 4 filing. |
Keywords
Form 4, InMed Pharmaceuticals, Alexandra Mancini, Stock Sale, Beneficial Ownership, Consultant
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.